Literature DB >> 25435594

ADVANTAGES OF MCNPX-BASED LATTICE TALLY OVER MESH TALLY IN HIGH-SPEED MONTE CARLO DOSE RECONSTRUCTION FOR PROTON RADIOTHERAPY.

Rui Zhang1, Jonas D Fontenot2, Dragan Mirkovic1, John S Hendricks3, Wayne D Newhauser4.   

Abstract

Monte Carlo simulations are increasingly used to reconstruct dose distributions in radiotherapy research studies. Many studies have used the MCNPX Monte Carlo code with a mesh tally for dose reconstructions. However, when the number of voxels in the simulated patient anatomy is large, the computation time for a mesh tally can become prohibitively long. The purpose of this work was to test the feasibility of using lattice tally instead of mesh tally for whole-body dose reconstructions. We did this by comparing the dosimetric accuracy and computation time of lattice tallies with those of mesh tallies for craniospinal proton irradiation. The two tally methods generated nearly identical dosimetric results, within 1% in dose and within 1 mm distance-to-agreement for 99% of the voxels. For a typical craniospinal proton treatment field, simulation speed was 4 to 17 times faster using the lattice tally than using the mesh tally, depending on the numbers of proton histories and voxels. We conclude that the lattice tally is an acceptable substitute for the mesh tally in dose reconstruction, making it a suitable potential candidate for clinical treatment planning.

Entities:  

Keywords:  dose reconstruction; lattice tally; mesh tally

Year:  2013        PMID: 25435594      PMCID: PMC4244884          DOI: 10.13182/nt13-a16995

Source DB:  PubMed          Journal:  Nucl Technol        ISSN: 0029-5450


  14 in total

1.  Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy.

Authors:  Jonas D Fontenot; Charles Bloch; David Followill; Uwe Titt; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.

Authors:  Wayne Newhauser; Jonas Fontenot; Yuanshui Zheng; Jerimy Polf; Uwe Titt; Nicholas Koch; Xiaodong Zhang; Radhe Mohan
Journal:  Phys Med Biol       Date:  2007-07-10       Impact factor: 3.609

3.  Monte Carlo study of neutron dose equivalent during passive scattering proton therapy.

Authors:  Yuanshui Zheng; Wayne Newhauser; Jonas Fontenot; Phil Taddei; Radhe Mohan
Journal:  Phys Med Biol       Date:  2007-06-27       Impact factor: 3.609

4.  Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate.

Authors:  Wayne Newhauser; Jonas Fontenot; Nicholas Koch; Lei Dong; Andrew Lee; Yuanshui Zheng; Laurie Waters; Radhe Mohan
Journal:  Phys Med Biol       Date:  2007-05-02       Impact factor: 3.609

5.  Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma.

Authors:  J Hérault; N Iborra; B Serrano; P Chauvel
Journal:  Med Phys       Date:  2005-04       Impact factor: 4.071

6.  The composition of body tissues.

Authors:  H Q Woodard; D R White
Journal:  Br J Radiol       Date:  1986-12       Impact factor: 3.039

7.  Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy.

Authors:  Basit S Athar; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-07-30       Impact factor: 3.609

8.  Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.

Authors:  Christina Zacharatou Jarlskog; Choonik Lee; Wesley E Bolch; X George Xu; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-01-10       Impact factor: 3.609

9.  The risk of developing a second cancer after receiving craniospinal proton irradiation.

Authors:  Wayne D Newhauser; Jonas D Fontenot; Anita Mahajan; David Kornguth; Marilyn Stovall; Yuanshui Zheng; Phillip J Taddei; Dragan Mirkovic; Radhe Mohan; James D Cox; Shiao Woo
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

10.  Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.

Authors:  Phillip J Taddei; Dragan Mirkovic; Jonas D Fontenot; Annelise Giebeler; Yuanshui Zheng; David Kornguth; Radhe Mohan; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

View more
  5 in total

Review 1.  The physics of proton therapy.

Authors:  Wayne D Newhauser; Rui Zhang
Journal:  Phys Med Biol       Date:  2015-03-24       Impact factor: 3.609

2.  Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers.

Authors:  Phillip J Taddei; Nabil Khater; Bassem Youssef; Rebecca M Howell; Wassim Jalbout; Rui Zhang; Fady B Geara; Annelise Giebeler; Anita Mahajan; Dragan Mirkovic; Wayne D Newhauser
Journal:  Biomed Phys Eng Express       Date:  2018-02-07

3.  Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.

Authors:  Wayne D Newhauser; Rui Zhang; Timothy G Jones; Annelise Giebeler; Phillip J Taddei; Robert D Stewart; Andrew Lee; Oleg Vassiliev
Journal:  Cancers (Basel)       Date:  2015-04-24       Impact factor: 6.639

Review 4.  A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments.

Authors:  Wayne D Newhauser; Amy Berrington de Gonzalez; Reinhard Schulte; Choonsik Lee
Journal:  Front Oncol       Date:  2016-02-10       Impact factor: 6.244

5.  Inter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation.

Authors:  Phillip J Taddei; Nabil Khater; Rui Zhang; Fady B Geara; Anita Mahajan; Wassim Jalbout; Angélica Pérez-Andújar; Bassem Youssef; Wayne D Newhauser
Journal:  Cancers (Basel)       Date:  2015-03-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.